prednisolone has been researched along with Co-infection in 9 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High cumulative prednisolone dose, baseline neutropenia, hypoalbuminemia, multiple cavities on CT chest, leukopenia, lymphopenia and raised inflammatory markers were associated with poor prognosis in severe COVID-19 patients with cavitating fungal pneumonia." | 4.12 | Clinical Profile, Risk Factors, and Therapeutic Outcome of Cavitating Fungal Pneumonia Coinfection in COVID-19 Patients: A Retrospective Analysis. ( Banerjee, S; Dua, R; Kumar, A; Mishra, M; Saini, LK; Sharma, P; Sindhwani, G, 2022) |
| " For the treatment of COVID-19 pneumonia, systemic and in-depth investigation is needed to determine the timing and dosage of glucocorticoids needed to inhibit overwhelming inflammatory response and not the protective immune response to COVID-19 pneumonia." | 1.56 | Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience. ( Hu, Y; Hu, Z; Li, L; Peng, P; Wang, T; Wang, X; Zhang, Z, 2020) |
| "Acute-onset CIDP resembles Guillain-Barre syndrome (GBS), a rapidly progressive disorder, and follows a chronic course." | 1.43 | Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: A case report. ( Choi, EH; Lim, JY; Lim, YH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A | 1 |
| Mishra, M | 1 |
| Banerjee, S | 1 |
| Saini, LK | 1 |
| Sharma, P | 1 |
| Dua, R | 1 |
| Sindhwani, G | 1 |
| Hu, Y | 1 |
| Wang, T | 1 |
| Hu, Z | 1 |
| Wang, X | 1 |
| Zhang, Z | 1 |
| Li, L | 1 |
| Peng, P | 1 |
| Nunn, A | 1 |
| Sturek, JM | 1 |
| Reuss, JE | 1 |
| Rein, MF | 1 |
| Heysell, SK | 1 |
| Nguyen, RH | 1 |
| Nuara, AA | 1 |
| Suwattee, P | 1 |
| Cockerell, CJ | 1 |
| Pandya, AG | 1 |
| Takagi, H | 1 |
| Hoshino, T | 2 |
| Naganuma, A | 1 |
| Koitabashi, E | 1 |
| Uehara, S | 1 |
| Sakamoto, N | 1 |
| Kudo, T | 1 |
| Ryusaki, K | 1 |
| Kakizaki, S | 1 |
| Okamoto, H | 1 |
| Ganesan, V | 1 |
| Mandal, J | 1 |
| Lim, JY | 1 |
| Lim, YH | 1 |
| Choi, EH | 1 |
| Koya, H | 1 |
| Yokohama, A | 1 |
| Miura, A | 1 |
| Mitsui, T | 1 |
| Koiso, H | 1 |
| Saitoh, T | 1 |
| Uchiumi, H | 1 |
| Handa, H | 1 |
| Hirato, J | 1 |
| Hiromura, K | 1 |
| Karasawa, M | 1 |
| Murakami, H | 1 |
| Tsukamoto, N | 1 |
| Nojima, Y | 1 |
| Kim, HS | 1 |
| Jeong, SH | 1 |
| Jang, JH | 1 |
| Myung, HJ | 1 |
| Kim, JW | 1 |
| Bang, SM | 1 |
| Song, SH | 1 |
| Kim, H | 1 |
| Yun, HS | 1 |
9 other studies available for prednisolone and Co-infection
| Article | Year |
|---|---|
Clinical Profile, Risk Factors, and Therapeutic Outcome of Cavitating Fungal Pneumonia Coinfection in COVID-19 Patients: A Retrospective Analysis.
Topics: Coinfection; COVID-19; Female; Humans; Influenza, Human; Male; Middle Aged; Pneumonia; Prednisolone; | 2022 |
Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betacoronavirus; Clinical Laboratory Techniques; Coinfec | 2020 |
Subacute loss of vision in one eye · rash on hands and feet · plaques with scaling on genitals · Dx?
Topics: Aged; Anti-Bacterial Agents; Anti-HIV Agents; Biopsy; Coinfection; Cyclopentolate; Diagnosis, Differ | 2017 |
Uveitis and desquamating rash of the palms and soles.
Topics: Anti-Bacterial Agents; Biopsy; Cholinergic Antagonists; Coinfection; Exanthema; Foot Dermatoses; Glu | 2013 |
Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV.
Topics: Antiviral Agents; Biomarkers; Coinfection; DNA, Viral; Drug Hypersensitivity Syndrome; Drug Substitu | 2013 |
Primary oral tuberculosis in a patient with lepromatous leprosy: Diagnostic dilemma.
Topics: Anti-Inflammatory Agents; Clofazimine; Coinfection; Female; Humans; Leprostatic Agents; Leprosy, Lep | 2016 |
Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: A case report.
Topics: Acute Disease; Adult; Azathioprine; Carrier State; Coinfection; Exercise Therapy; Follow-Up Studies; | 2016 |
[Glossitis by mixed infection of cytomegalovirus and herpes simplex virus during therapy for pure red cell aplasia complicated with Good syndrome].
Topics: Agammaglobulinemia; Aged; Coinfection; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combi | 2011 |
Coinfection of hepatitis A virus genotype IA and IIIA complicated with autoimmune hemolytic anemia, prolonged cholestasis, and false-positive immunoglobulin M anti-hepatitis E virus: a case report.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Cholestasis; Coinfection; Genotype; | 2011 |